ID   SRTD1_HUMAN             Reviewed;         236 AA.
AC   Q9UHV2; Q9BUE7;
DT   11-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 2.
DT   24-JAN-2024, entry version 162.
DE   RecName: Full=SERTA domain-containing protein 1;
DE   AltName: Full=CDK4-binding protein p34SEI1;
DE            Short=SEI-1;
DE            Short=p34(SEI-1);
DE   AltName: Full=Transcriptional regulator interacting with the PHD-bromodomain 1;
DE            Short=TRIP-Br1;
GN   Name=SERTAD1; Synonyms=SEI1, TRIPBR1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH CDK4, AND VARIANT ALA-31.
RX   PubMed=10580009; DOI=10.1101/gad.13.22.3027;
RA   Sugimoto M., Nakamura T., Ohtani N., Hampson L., Hampson I.N.,
RA   Shimamoto A., Furuichi Y., Okumura K., Niwa S., Taya Y., Hara E.;
RT   "Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1).";
RL   Genes Dev. 13:3027-3033(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH E2F1 AND TFDP1, DEVELOPMENTAL
RP   STAGE, AND VARIANT ALA-31.
RX   PubMed=11331592; DOI=10.1093/emboj/20.9.2273;
RA   Hsu S.-I., Yang C.M., Sim K.G., Hentschel D.M., O'Leary E., Bonventre J.V.;
RT   "TRIP-Br: a novel family of PHD zinc finger- and bromodomain-interacting
RT   proteins that regulate the transcriptional activity of E2F-1/DP-1.";
RL   EMBO J. 20:2273-2285(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-31.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   DEVELOPMENTAL STAGE, AND UBIQUITINATION.
RX   PubMed=18316374; DOI=10.1074/jbc.m708365200;
RA   Cheong J.K., Gunaratnam L., Hsu S.I.;
RT   "CRM1-mediated nuclear export is required for 26 S proteasome-dependent
RT   degradation of the TRIP-Br2 proto-oncoprotein.";
RL   J. Biol. Chem. 283:11661-11676(2008).
CC   -!- FUNCTION: Acts at E2F-responsive promoters as coregulator to integrate
CC       signals provided by PHD- and/or bromodomain-containing transcription
CC       factors. Stimulates E2F1/TFDP1 transcriptional activity. Renders the
CC       activity of cyclin D1/CDK4 resistant to the inhibitory effects of
CC       CDKN2A/p16INK4A.
CC   -!- SUBUNIT: Interacts with the PHD-bromodomain of TIF1, TRIM28/TIF1B and
CC       p300/CBP. Interacts with E2F1 and TFDP1; modulates transactivation
CC       activity of TFDP1/E2F complexes. Also interacts with CDK4.
CC       {ECO:0000269|PubMed:10580009, ECO:0000269|PubMed:11331592}.
CC   -!- INTERACTION:
CC       Q9UHV2; Q9NX04: AIRIM; NbExp=3; IntAct=EBI-748601, EBI-8643161;
CC       Q9UHV2; O94817: ATG12; NbExp=3; IntAct=EBI-748601, EBI-746742;
CC       Q9UHV2; Q9H503-2: BANF2; NbExp=3; IntAct=EBI-748601, EBI-11977289;
CC       Q9UHV2; Q13111: CHAF1A; NbExp=3; IntAct=EBI-748601, EBI-1020839;
CC       Q9UHV2; Q96Q77: CIB3; NbExp=3; IntAct=EBI-748601, EBI-10292696;
CC       Q9UHV2; Q9BW66: CINP; NbExp=3; IntAct=EBI-748601, EBI-739784;
CC       Q9UHV2; P61024: CKS1B; NbExp=3; IntAct=EBI-748601, EBI-456371;
CC       Q9UHV2; Q6NZ36-4: FAAP20; NbExp=3; IntAct=EBI-748601, EBI-12013806;
CC       Q9UHV2; Q9BVV2: FNDC11; NbExp=3; IntAct=EBI-748601, EBI-744935;
CC       Q9UHV2; Q8IVS8: GLYCTK; NbExp=3; IntAct=EBI-748601, EBI-748515;
CC       Q9UHV2; P42858: HTT; NbExp=3; IntAct=EBI-748601, EBI-466029;
CC       Q9UHV2; Q9H8E8: KAT14; NbExp=3; IntAct=EBI-748601, EBI-750907;
CC       Q9UHV2; Q9NSK0: KLC4; NbExp=3; IntAct=EBI-748601, EBI-949319;
CC       Q9UHV2; Q9P2K6: KLHL42; NbExp=4; IntAct=EBI-748601, EBI-739890;
CC       Q9UHV2; Q9BYU1: PBX4; NbExp=3; IntAct=EBI-748601, EBI-10302990;
CC       Q9UHV2; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-748601, EBI-79165;
CC       Q9UHV2; Q8WWB5: PIH1D2; NbExp=3; IntAct=EBI-748601, EBI-10232538;
CC       Q9UHV2; Q99633: PRPF18; NbExp=3; IntAct=EBI-748601, EBI-2798416;
CC       Q9UHV2; Q9UIG4: PSORS1C2; NbExp=3; IntAct=EBI-748601, EBI-11974061;
CC       Q9UHV2; Q9UDX3: SEC14L4; NbExp=3; IntAct=EBI-748601, EBI-10320311;
CC       Q9UHV2; Q8WTS6: SETD7; NbExp=2; IntAct=EBI-748601, EBI-1268586;
CC       Q9UHV2; Q7RTT5: SSX7; NbExp=3; IntAct=EBI-748601, EBI-12879730;
CC       Q9UHV2; Q86VK4-3: ZNF410; NbExp=3; IntAct=EBI-748601, EBI-11741890;
CC       Q9UHV2; PRO_0000449633 [P0DTD1]: rep; Xeno; NbExp=3; IntAct=EBI-748601, EBI-25492395;
CC   -!- DEVELOPMENTAL STAGE: Transcript levels remain constant in all phases of
CC       the cell cycle. In contrast, protein levels accumulate at the G1/S
CC       phase boundary and decrease progressively through S phase until G2/M
CC       phase is reached. {ECO:0000269|PubMed:11331592,
CC       ECO:0000269|PubMed:18316374}.
CC   -!- PTM: Polyubiquitinated, which promotes proteasomal degradation.
CC       {ECO:0000269|PubMed:18316374}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/sei1/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF117959; AAF08349.1; -; mRNA.
DR   EMBL; AF366402; AAK52831.1; -; mRNA.
DR   EMBL; AY130860; AAM77800.1; -; Genomic_DNA.
DR   EMBL; BC002670; AAH02670.1; -; mRNA.
DR   CCDS; CCDS12557.1; -.
DR   RefSeq; NP_037508.2; NM_013376.3.
DR   AlphaFoldDB; Q9UHV2; -.
DR   BioGRID; 118987; 75.
DR   CORUM; Q9UHV2; -.
DR   IntAct; Q9UHV2; 68.
DR   MINT; Q9UHV2; -.
DR   STRING; 9606.ENSP00000350633; -.
DR   BioMuta; SERTAD1; -.
DR   DMDM; 67477469; -.
DR   EPD; Q9UHV2; -.
DR   MassIVE; Q9UHV2; -.
DR   PaxDb; 9606-ENSP00000350633; -.
DR   PeptideAtlas; Q9UHV2; -.
DR   Antibodypedia; 16970; 214 antibodies from 31 providers.
DR   DNASU; 29950; -.
DR   Ensembl; ENST00000357949.5; ENSP00000350633.4; ENSG00000197019.5.
DR   GeneID; 29950; -.
DR   KEGG; hsa:29950; -.
DR   MANE-Select; ENST00000357949.5; ENSP00000350633.4; NM_013376.4; NP_037508.2.
DR   UCSC; uc002ont.6; human.
DR   AGR; HGNC:17932; -.
DR   CTD; 29950; -.
DR   DisGeNET; 29950; -.
DR   GeneCards; SERTAD1; -.
DR   HGNC; HGNC:17932; SERTAD1.
DR   HPA; ENSG00000197019; Low tissue specificity.
DR   MIM; 617850; gene.
DR   neXtProt; NX_Q9UHV2; -.
DR   OpenTargets; ENSG00000197019; -.
DR   PharmGKB; PA134957023; -.
DR   VEuPathDB; HostDB:ENSG00000197019; -.
DR   eggNOG; ENOG502S52T; Eukaryota.
DR   GeneTree; ENSGT00940000154733; -.
DR   HOGENOM; CLU_1229598_0_0_1; -.
DR   InParanoid; Q9UHV2; -.
DR   OMA; LAVDTWW; -.
DR   OrthoDB; 4610821at2759; -.
DR   PhylomeDB; Q9UHV2; -.
DR   TreeFam; TF101069; -.
DR   PathwayCommons; Q9UHV2; -.
DR   SignaLink; Q9UHV2; -.
DR   BioGRID-ORCS; 29950; 13 hits in 1161 CRISPR screens.
DR   ChiTaRS; SERTAD1; human.
DR   GeneWiki; SERTAD1; -.
DR   GenomeRNAi; 29950; -.
DR   Pharos; Q9UHV2; Tbio.
DR   PRO; PR:Q9UHV2; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9UHV2; Protein.
DR   Bgee; ENSG00000197019; Expressed in vena cava and 181 other cell types or tissues.
DR   ExpressionAtlas; Q9UHV2; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0016528; C:sarcoplasm; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:ProtInc.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0000079; P:regulation of cyclin-dependent protein serine/threonine kinase activity; TAS:ProtInc.
DR   InterPro; IPR009263; SERTA_dom.
DR   PANTHER; PTHR16277; CELL DIVISION CYCLE ASSOCIATED PROTEIN 4/SERTA DOMAIN-CONTAINING PROTEIN 2; 1.
DR   PANTHER; PTHR16277:SF12; SERTA DOMAIN-CONTAINING PROTEIN 1; 1.
DR   Pfam; PF06031; SERTA; 1.
DR   PROSITE; PS51053; SERTA; 1.
DR   Genevisible; Q9UHV2; HS.
PE   1: Evidence at protein level;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..236
FT                   /note="SERTA domain-containing protein 1"
FT                   /id="PRO_0000191611"
FT   DOMAIN          38..85
FT                   /note="SERTA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00396"
FT   REGION          1..20
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          189..211
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VARIANT         31
FT                   /note="T -> A (in dbSNP:rs268687)"
FT                   /evidence="ECO:0000269|PubMed:10580009,
FT                   ECO:0000269|PubMed:11331592, ECO:0000269|Ref.3"
FT                   /id="VAR_015881"
SQ   SEQUENCE   236 AA;  24704 MW;  8659505783FBF50B CRC64;
     MLSKGLKRKR EEEEEKEPLA VDSWWLDPGH TAVAQAPPAV ASSSLFDLSV LKLHHSLQQS
     EPDLRHLVLV VNTLRRIQAS MAPAAALPPV PSPPAAPSVA DNLLASSDAA LSASMASLLE
     DLSHIEGLSQ APQPLADEGP PGRSIGGAAP SLGALDLLGP ATGCLLDDGL EGLFEDIDTS
     MYDNELWAPA SEGLKPGPED GPGKEEAPEL DEAELDYLMD VLVGTQALER PPGPGR
//